Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 31.75
-0.25 (-0.78%)
Jul 30, 2026, 1:30 PM CST
Apex Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,906 | 1,945 | 1,852 | 1,677 | 2,244 | 2,132 |
Revenue Growth | -2.78% | 5.00% | 10.48% | -25.29% | 5.28% | 6.30% |
Gross Profit Gross Profit Growth | 551.75 | 538.74 | 521.34 | 531.12 | 576.84 | 571.51 |
Operating Income Operating Income Growth | 171.74 | 140.73 | 128.46 | 141.72 | 176.56 | 204.95 |
Net Income Net Income Growth | 182.14 | 162.89 | 128 | 115.78 | 181.79 | 202.22 |
Earnings Per Share EPS Growth | 1.81 | 1.62 | 1.27 | 1.15 | 1.81 | 1.93 |
EPS Growth | 13.18% | 27.56% | 10.44% | -36.46% | -6.16% | 120.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 798.36 | 885.18 | 715.86 | 683.99 | 898.35 | 912.27 |
Italy Italy Growth | 567.03 | 535.58 | 568.53 | 537.88 | 661.25 | 740.2 |
Austria Austria Growth | 258.92 | 276.07 | 245.12 | 142.14 | 365.42 | 146.12 |
Taiwan Taiwan Growth | 78.53 | 75.86 | 77.37 | 73.85 | 93.47 | 71.42 |
Others Others Growth | 179.98 | 149.16 | 211.04 | 190.85 | 170.57 | 212.29 |
Mainland China Mainland China Growth | - | 23.06 | 34.29 | 47.83 | 55.12 | 49.35 |
Total Total Growth | 1,906 | 1,945 | 1,852 | 1,677 | 2,244 | 2,132 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 667.92 | 644.37 | 598.78 | 443.91 | 397.53 | 625.05 |
Total Debt Total Debt Growth | 108.4 | 109.67 | 122.96 | 153.4 | 180.68 | 284.55 |
Net Cash (Debt) Net Cash Growth | 559.52 | 534.69 | 475.83 | 290.52 | 216.85 | 340.5 |
Net Cash Growth | 16.95% | 12.37% | 63.79% | 33.97% | -36.31% | 10.11% |
Net Cash Per Share Net Cash Per Share Growth | 5.56 | 5.32 | 4.74 | 2.90 | 2.15 | 3.22 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 208.43 | 160.12 | 328.67 | 230.39 | 26.62 | 179.87 |
Capital Expenditures CapEx Growth | -20.5 | -15.26 | -28.24 | -21.91 | -36.58 | -26.59 |
Free Cash Flow Free Cash Flow Growth | 187.93 | 144.86 | 300.43 | 208.48 | -9.97 | 153.28 |
Free Cash Flow Growth | -22.29% | -51.78% | 44.10% | - | - | -34.87% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.95% | 27.70% | 28.15% | 31.68% | 25.70% | 26.81% |
Operating Margin | 9.01% | 7.24% | 6.94% | 8.45% | 7.87% | 9.62% |
Pretax Margin | 10.31% | 9.76% | 8.27% | 8.41% | 8.89% | 8.68% |
Profit Margin | 9.56% | 8.38% | 6.91% | 6.91% | 8.10% | 9.49% |
FCF Margin | 9.86% | 7.45% | 16.22% | 12.44% | -0.44% | 7.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.300 | 1.300 | 1.200 | 1.100 | 1.400 | 1.300 |
Dividend Per Share Growth | 8.33% | 8.33% | 9.09% | -21.43% | 7.69% | 18.18% |
Dividend Yield | 4.10% | 4.46% | 4.34% | 3.06% | 6.46% | 6.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.67 | 18.68 | 23.50 | 34.79 | 14.05 | 12.85 |
Forward PE | - | 13.11 | 13.11 | 13.11 | 13.11 | 13.11 |
P/FCF Ratio | 17.02 | 21.01 | 10.01 | 19.32 | - | 16.95 |
PS Ratio | 1.68 | 1.57 | 1.62 | 2.40 | 1.14 | 1.22 |